Solu-cortef (hydrocortisone) powder infusions 100 mg. №1


Manufacturer: Belgium



Conditions in which it is desirable to obtain a rapid and intense effect of the action of corticosteroids. Endocrine disorders. Rheumatic diseases as an adjunctive therapy for short-term use (to help the patient survive an acute episode or exacerbation). Collagenosis, during exacerbation or as supportive therapy in individual cases. Dermatology diseases. Allergic conditions: control of severe allergic conditions or allergic conditions that lead to disability and are not amenable to traditional treatment. Ophthalmic diseases: severe acute and chronic allergic and inflammatory processes with eye damage. Gastrointestinal diseases to help the patient go through a critical period. Respiratory diseases. Hematological diseases. Neoplastic diseases, palliative treatment of such diseases: acute leukemia in children; leukemia and lymphoma in adults. Conditions accompanied by edema: for the induction of diuresis or remission of proteinuria in nephrotic syndrome, without uremia, idiopathic type or due to lupus erythematosus. Immediate conditions: shock that has developed due to insufficiency of the adrenal cortex, or shock, insensitive to traditional therapy, in case of possible insufficiency of the adrenal cortex; acute allergic conditions (asthmatic status, anaphylactic reactions, insect bites, etc.) that do not occur after epinephrine. Other: Trichinosis with involvement of nerves or myocardium; tuberculous meningitis with subarachnoid blockage or threat of blockage, when used in conjunction with appropriate anti-tuberculosis chemotherapy.